China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiation Dosimetry and Preliminary Diagnostic Performance of 68Ga-DOTA- CHK5 in Patients with Malignant Tumours'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135373
Registration Time: 2026/10/29
Type: Interventional study
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348315
Published by HT Digital Content Services with permission from Health Daily Digest....